|
Identifying Early Psychosis in Primary Care and Connecting to Care
|
Research Initiative
|
HRSA
|
NIMH
|
The Health Resources and Services Administration (HRSA) and National Institute of Mental Health (NIMH) are supporting developmental of testing of a brief early psychosis screening instrument. This instrument may be used in a primary care setting to identify people with psychosis at the earliest possible opportunity and connect them to an early psychosis treatment program.
|
|
Image-guided Interventional Therapeutics
|
Research Initiative
|
FDA
|
CC, NCI
|
This collaboration will lead to safer and more effective treatment planning and performance of image-guided interventions and therapeutic drug delivery. The results of all of these studies of image guided interventions and related technologies and the models used to study them will have a direct impact on the effectiveness and consistency of the FDA Center for Devices and Radiological Health''s preclinical review of device applications while meeting the primary research goal of optimizing image guided interventions and pre-clinical modeling of those interventions. Regulatory science and translational therapeutics have overlapping goals when it comes to drugs and devices combination therapies.
|
|
Immunology Interest Group
|
Meeting/ Workshop
|
FDA
|
NCI, CC, NCCIH, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, OD/OIR
|
The NIH Immunology Interest Group brings together immunologists from across all NIH institutes as well as the FDA .The two major activities of the IG are a Wednesday afternoon lecture series highlighting world class immunologists and intramural immunologists and an annual workshop where up to 350 NIH/FDA immunologists get together to present their work to the community.
|
|
Immunotoxicity of Workplace Xenobiotics
|
Research Initiative
|
CDC
|
NIEHS
|
The Immunotoxicity of Workplace Xenobiotics interagency agreement functions to enhance the immunotoxicological evaluations of humans exposed to quantifiable levels of xenobiotics in the environment and workplace. To date work funded by this IAG has examined immune responses in diverse worker populations including farmers, health care and hospital workers, firefighters, manufacturing workers (nano materials, lead batteries), etc. A variety of occupational populations in the agriculture, forestry, service, and manufacturing sectors are at elevated risk of fungal exposures due to workers handling contaminated cellulose-based materials. The current projects focus on the growing concern of personal exposure to fungal bioaerosols and the potential toxicity of mold and mold-related related xenobiotics from contaminated materials.
|
|
Improving Genomics/Omics Technical Standards and Molecular Tools for Prebiotic Probiotic Research and Development Working Group
|
Research Initiative
|
CDC, FDA, OS
|
NCCIH, NCI, NHGRI, NIDA, NLM
|
The overarching workgroup effort is to enhance research initiatives/resource development as IAA workgroup members committed to sustain and accelerate translatability of validation analytics and reference datasets using omic and other multi-omic substitutable [SMART] tools, devices, and HL-7 FHIR technologies to support rapid and efficient interoperability with electronic health records and clinical decision support systems. A second goal is to coordinate and plan trans-NIH and Inter-agency meetings, workshops and initiatives with greater efficiency of ICO resources and expertise between agencies. Innovative technologies like HL-7 SMART on FHIR have been demonstrated to enhance health information exchange, affordably and accurately. Novel device monitoring using reference standards including, FDA Precision and NIST nanofabrication, multi-omics and modeling strategies can be integrated to improve validation and standards biosafety, risk monitoring of adverse drug events, food safety, overuse and resistance to antibiotics, and emerging infection. The intent originated in April 2016 with an Initiative planning meeting that are now ongoing for IAA partnered PCORI; other IAA collaboratives in progress.
|
|
Influenza Risk Management Meeting
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
NIAID
|
The Influenza Risk Management Meetings provide members (including ASPR/BARDA, CDC, FDA, and NIH) with a venue to discuss issues relating to the U.S. Department of Health and Human Services (HHS) response to pandemic influenza. Subjects for discussion include but are not limited to considerations of vaccine and antiviral stockpiles and clinical trial response to influenza outbreaks such as H7N9 and H3N2v.
|
|
Influenza Vaccine Manufacturing Improvement Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
NIAID
|
The Influenza Vaccine Manufacturing Improvement Group aims to optimize donor strains, improve sterility assays, and develop alternative potency assays.
|
|
Innovation in Organ Transplantation
|
Meeting/ Workshop
|
HRSA
|
NIAID
|
This HRSA-led, multi-agency workshop addressed issues that present real or potential barriers to progress in clinical research in organ transplantation, including structural impediments to research innovation; special considerations in assessing transplant outcomes; and establishing review processes for research deserving special consideration.
|
|
Institute of Medicine Consensus Study on Accessible and Affordable Hearing Health Care for Adults
|
Other
|
CDC, FDA
|
NIDCD, NIA
|
This study provides background on the importance of hearing to individual and societal health including issues such as isolation, social connectivity, well-being, and economic productivity. It will examine federal regulations for non-surgical hearing aid dispensing by asking if current regulations provide a clinically meaningful benefit to adults with hearing loss and what the required federal regulatory paradigm should be. The study will also address the affordability of non-surgical devices and services. It will look at how affordability can be improved, how current approaches can be used or modified to increase access, how new and innovative approaches (such as telehealth, mobile health, and team-based care) can be used to increase access and affordability, and will discuss challenges for select populations such as older adults and transitioning young adults. The committee will provide short- and long-term recommendations for solutions to these questions.
|
|
Integrating Prevention Science and Public Policy
|
Meeting/ Workshop
|
ACF, CDC
|
NIAAA, NCI, NHLBI, NICHD, NIDA, NIMH, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP, OD/DPCPSI/ORWH
|
The Society for Prevention Research (SPR) envisions a wellness-oriented society in which evidenced-based programs and policies are continuously applied to improve the health and wellbeing of its citizens. The SPR Annual Meeting provides unique opportunities to advance this vision by providing an integrated forum for the exchange of new concepts, methods, and results from prevention and public health-related research, and communication between scientists, public policy leaders and practitioners concerning the implementation of evidence-based preventive interventions.
|